세계의 유전자 발현 분석 시장 (~2029년) : 제품별 (시약, 효소, 키트, DNA 칩, PCR, NGS, DNA 마이크로어레이), 서비스별 (RNA 시퀀싱, 바이오인포매틱스), 용도별 (신약개발, 임상진단), 최종 용도별

■ 영문 제목 : Gene Expression Analysis Market by Product (Reagents, Enzymes, kits, DNA Chips, PCR, NGS, DNA Microarray), Service (RNA Sequencing, Bioinformatics), Application (Drug discovery & development, clinical diagnostics), End User - Global Forecast to 2029

MarketsandMarkets 회사가 출판한 조사자료로, 코드는 BT2236-24 입니다.■ 상품코드 : BT2236-24
■ 조사/발행회사 : MarketsandMarkets
■ 발행일 : 2024년 3월
■ 페이지수 : 370
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : Email (주문후 24시간내 납품)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 바이오
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD4,950 ⇒환산￦6,682,500견적의뢰/주문/질문
Multi User (Five User)USD6,650 ⇒환산￦8,977,500견적의뢰/주문/질문
Corporate LicenseUSD8,150 ⇒환산￦11,002,500견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
"세계의 유전자 발현 분석 시장은 2024년 약 42억 달러에서 2029년 62억 달러로 연평균 8.1%의 성장률을 보일 것으로 예상됩니다." 이 시장의 성장은 유전체학 연구에 대한 투자가 증가하고 있으며, 유전학 연구를 위한 정부 자금의 가용성 또한 시장 확대에 기여하고 있습니다. 유전자 발현 분석 분야는 유전자 조절 및 분자 메커니즘에 대한 이해도가 높아지면서 진화하고 있으며, 유전자 발현 분석 시장은 지속적인 성장과 혁신을 거듭할 것으로 예상됩니다.

"2023년 기기별 점유율은 PCR 기기 부문이 가장 클 것 입니다."
2023년 글로벌 유전자 발현 분석 시장에서 PCR 장비 부문은 제품 및 서비스 장비 하위 부문에서 가장 큰 점유율을 차지했으며, PCR 장비는 제약, 생명공학, 학술 연구, 임상 진단, 법의학 등 다양한 산업에서 광범위하게 사용되고 있습니다. 이러한 광범위한 적용 범위는 PCR 장비의 큰 시장 점유율에 기여했습니다.

"아시아 태평양 지역은 2024-2029 예측 기간 동안 시장에서 가장 높은 CAGR로 성장할 것 입니다."
아시아 태평양 지역은 예측 기간 동안 가장 높은 성장률을 보일 것으로 예상됩니다. 이 지역은 프로테오믹스 및 유전체학 연구 확대, 연구 자금 증가, 제약 및 생명공학 기업의 투자 확대, 개인맞춤형 치료제에 대한 인식 증가에 힘입어 급성장할 것으로 예상됩니다. 인도와 중국은 아시아 태평양 지역에서 가장 높은 성장세를 보일 것으로 예상되며, 특히 진단의 이점과 관련된 저렴한 가격과 인식의 증가가 그 이유입니다.

본 보고서를 위해 실시한 1차 인터뷰는 다음과 같이 분류됩니다.
- 응답자별 : 공급측 70%, 수요측 30%.
- 응답자 직급별 : 관리자 : 45%, CXO 및 이사 : 30%, 임원 : 25%, 경영진 : 25%.
- 지역별 북미 : 45%, 유럽 : 20%, 아시아 태평양 : 20%, 중남미 : 10%, 중동/아프리카 : 5%.

보고서 수록 기업 목록
• Thermo Fisher Scientific Inc (US)
• Bio-Rad Laboratories Inc. (US)
• Illumina Inc (US)
• QIAGEN (Netherlands)
• F. Hoffmann-La Roche (Switzerland)
• Revvity (US)
• PacBio (US)
• Agilent Technologies Inc (US)
• Oxford Gene Technology IP Limited (UK)
• BGI (China)
• Eurofins Scientific (Luxembourg)
• Standard BioTools (US)
• Oxford Nanopore Technologies plc (UK)
• GenScript (US)
• Takara Bio Inc (Japan)
• 10x Genomics (US)
• Zymo Research Corporation (US)
• Twist Bioscience (US)
• Promega Corporation (US)
• LGC Limited (UK)
• CD Genomics (US)
• NanoString Technologies Inc. (US)
• BioSpyder, Inc (US)
• Integrated DNA Technologies, Inc (US)
• New England Biolabs (US).

조사 범위
본 조사 보고서는 유전자 발현 분석 시장을 제품-서비스(기기, 시약-소모품, 서비스(유전자 발현 분석 서비스, 바이오 인포매틱스 서비스)), 용도(임상진단, 신약-의약품 개발, 기타(발생생물학, 약리유전체학, 환경반응, 법의학 연구, 농업 연구)), 최종 용도(제약/바이오텍 기업, 학술/연구기관, 기타(임상연구소, CRO, 법의학연구소, 농업/환경단체)), 지역별(북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카)로 구분하고 있습니다. 이 보고서는 유전자 발현 분석 시장의 성장에 영향을 미치는 촉진 요인, 과제, 기회, 동향 등 주요 요인에 대한 상세한 정보를 다루고 있습니다. 이 보고서는 주요 산업 플레이어의 비즈니스 프로필, 제품/서비스 제공 및 제휴, 파트너십, 사업 확장, 합의, 인수, 최근 개발 등 유전자 발현 분석 시장에서의 전략적 이니셔티브에 대한 통찰력을 제공합니다. 또한, 유전자 발현 분석 시장 생태계의 주요 기업 및 신생 스타트업의 경쟁 분석도 다루고 있습니다.

보고서 구매의 주요 이점
이 보고서는 전체 유전자 발현 분석 시장과 그 하위 부문의 수익에 대한 가장 근접한 추정치를 제공함으로써 시장 리더와 신규 진입자에게 도움이 될 것입니다. 또한, 이해관계자들이 경쟁 현황을 더 잘 이해하고 더 많은 통찰력을 확보하여 비즈니스를 더 잘 포지셔닝하고 적절한 시장 진입 전략을 수립할 수 있도록 돕습니다. 이 보고서는 이해관계자들이 시장의 맥박을 이해하고 주요 시장 동인, 저해 요인, 기회 및 과제에 대한 정보를 제공할 수 있도록 합니다.

이 보고서는 다음 사항에 대한 통찰력을 제공합니다.
- 시장 성장에 영향을 미치는 주요 촉진 요인(유전자 편집 기술 발전, 유전체 연구 자금 지원 증가, 치료 응용에 대한 선호도 증가, 시퀀싱 비용 감소), 저해 요인(높은 장비 및 소모품 비용, 데이터 프라이버시 및 보안 관련 우려), 기회(비의료 분야에서의 적용 확대, 머신러닝과 AI, 단일 세포 분석에 대한 관심 증가), 도전 과제(승인까지 걸리는 시간, 데이터 해석의 어려움)에 대한 분석을 합니다.
- 제품 개발/혁신 : 유전자 발현 분석 시장의 신제품에 대한 심층적인 인사이트를 제공합니다.
- 시장 개발 : 유리한 시장에 대한 포괄적인 정보 - 본 보고서는 다양한 지역의 시장을 분석합니다.
- 시장 다각화 : 유전자 발현 분석 시장의 신제품/서비스, 미개척 지역, 최근 개발 및 투자에 대한 상세 정보를 제공합니다.
- 경쟁사 평가 : Thermo Fisher Scientific Inc (US), Bio-Rad Laboratories Inc. (US), Illumina Inc (US), QIAGEN (Netherlands), F. Hoffmann-La Roche (Switzerland), Revvity (US), PacBio (US), Agilent Technologies Inc (US), Oxford Gene Technology IP Limited (UK), BGI (China), Eurofins Scientific (Luxembourg), Standard BioTools (US), Oxford Nanopore Technologies plc (UK), GenScript (US), Takara Bio Inc (Japan), 10x Genomics (US), Zymo Research Corporation (US), Twist Bioscience (US), Promega Corporation (US), LGC Limited (UK), CD Genomics (US), NanoString Technologies Inc. (US), BioSpyder, Inc (US), Integrated DNA Technologies, Inc (US) and New England Biolabs (US) 등의 기업 정보를 포함하고 있습니다.
■ 보고서 개요

1 서론
2 조사 방법
3 개요
4 프리미엄 인사이트
5 시장 개요
6 세계의 유전자 발현 분석 시장 규모 : 제품 및 서비스별
7 세계의 유전자 발현 분석 시장 규모 : 응용 분야별
8 세계의 유전자 발현 분석 시장 규모 : 최종 용도별
9 세계의 유전자 발현 분석 시장 규모 : 지역별
10 경쟁 현황
11 기업 정보
12 부록

■ 보고서 목차

1 INTRODUCTION 31
1.1 STUDY OBJECTIVES 31
1.2 MARKET DEFINITION 31
1.2.1 INCLUSIONS & EXCLUSIONS 31
1.3 MARKET SCOPE 32
1.3.1 MARKETS COVERED 32
1.3.2 REGIONS COVERED 33
1.3.3 YEARS CONSIDERED 33
1.3.4 CURRENCY CONSIDERED 34
1.4 RESEARCH LIMITATIONS 34
1.5 STAKEHOLDERS 34
1.6 SUMMARY OF CHANGES 35
1.7 RECESSION IMPACT 35
2 RESEARCH METHODOLOGY 36
2.1 RESEARCH DATA 36
FIGURE 1 RESEARCH DESIGN 36
2.1.1 SECONDARY DATA 37
2.1.2 PRIMARY DATA 38
FIGURE 2 GENE EXPRESSION ANALYSIS MARKET: BREAKDOWN OF PRIMARIES 38
2.2 MARKET SIZE ESTIMATION 39
FIGURE 3 MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 39
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2023 40
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC INC.: REVENUE SHARE ANALYSIS, 2023 40
2.2.1 INSIGHTS FROM PRIMARIES 42
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS 42
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT & SERVICE, APPLICATION, AND END USER) 42
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 42
2.3 GROWTH RATE ASSUMPTIONS 43
FIGURE 8 GENE EXPRESSION ANALYSIS MARKET: CAGR PROJECTIONS (2024–2029) 44
FIGURE 9 GENE EXPRESSION ANALYSIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES 44
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 45
FIGURE 10 DATA TRIANGULATION METHODOLOGY 45
2.5 STUDY ASSUMPTIONS 46
2.6 RISK ANALYSIS 46
2.7 RECESSION IMPACT ANALYSIS 46
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2024–2028 (% GROWTH) 47
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION) 47
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION) 47
3 EXECUTIVE SUMMARY 48
FIGURE 11 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION) 48
FIGURE 12 GENE EXPRESSION SERVICES MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 49
FIGURE 13 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 49
FIGURE 14 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION) 50
FIGURE 15 GEOGRAPHIC SNAPSHOT OF GENE EXPRESSION ANALYSIS MARKET 51
4 PREMIUM INSIGHTS 52
4.1 GENE EXPRESSION ANALYSIS MARKET OVERVIEW 52
FIGURE 16 ADVANCEMENTS IN GENE EDITING TECHNOLOGIES TO DRIVE MARKET 52
4.2 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2023 53
FIGURE 17 PRODUCT & SERVICE SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 53
4.3 GENE EXPRESSION ANALYSIS MARKET SHARE, BY PRODUCT & SERVICE, 2024 VS. 2029 53
FIGURE 18 PRODUCT & SERVICE SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 53
4.4 GENE EXPRESSION ANALYSIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 54
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD 54
5 MARKET OVERVIEW 55
5.1 INTRODUCTION 55
5.2 MARKET DYNAMICS 55
FIGURE 20 GENE EXPRESSION ANALYSIS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 55
5.2.1 DRIVERS 56
5.2.1.1 Advancements in gene editing technologies 56
5.2.1.2 Increasing funding initiatives for genomic research 57
5.2.1.3 Growing preference for therapeutic applications 57
5.2.1.4 Declining costs of sequencing technologies 58
FIGURE 21 COST OF HUMAN WHOLE-GENOME SEQUENCING, 2001–2022 59
5.2.2 RESTRAINTS 59
5.2.2.1 High cost of instruments & consumables 59
5.2.2.2 Concerns associated with data privacy and security 60
5.2.3 OPPORTUNITIES 61
5.2.3.1 High growth potential across non-clinical applications 61
5.2.3.2 Machine learning and AI 62
5.2.3.3 Growing focus on single-cell analysis 63
5.2.4 CHALLENGES 64
5.2.4.1 Extensive timelines for product approval 64
5.2.4.2 Data interpretation challenges 64
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 65
FIGURE 22 REVENUE SHIFT TOWARDS GENE EXPRESSION ANALYSIS COMPANIES 65
5.4 PRICING ANALYSIS 66
5.4.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT 66
TABLE 4 GENE EXPRESSION ANALYSIS PRODUCT PRICE 66
5.5 VALUE CHAIN ANALYSIS 67
FIGURE 23 GENE EXPRESSION ANALYSIS MARKET: VALUE CHAIN ANALYSIS 68
5.6 SUPPLY CHAIN ANALYSIS 69
FIGURE 24 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 69
TABLE 5 GENE EXPRESSION ANALYSIS MARKET: SUPPLY CHAIN ANALYSIS 70
5.7 ECOSYSTEM ANALYSIS 71
FIGURE 25 GENE EXPRESSION ANALYSIS MARKET ECOSYSTEM 71
5.7.1 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS 72
TABLE 6 GENE EXPRESSION ANALYSIS MARKET: REAGENT & CONSUMABLE VENDORS 72
5.7.2 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS 72
TABLE 7 GENE EXPRESSION ANALYSIS MARKET: INSTRUMENT VENDORS 72
5.7.3 GENE EXPRESSION ANALYSIS MARKET: END USERS 73
TABLE 8 GENE EXPRESSION ANALYSIS MARKET: END USERS 73
5.7.4 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73
TABLE 9 GENE EXPRESSION ANALYSIS MARKET: REGULATORY BODIES 73
5.8 TECHNOLOGY ANALYSIS 74
5.9 PATENT ANALYSIS 75
5.9.1 PATENTS FILED, BY DOCUMENT TYPE, 2014–2024 75
TABLE 10 PATENTS FILED, 2014–2024 75
5.9.2 INNOVATION & PATENT APPLICATIONS 75
FIGURE 26 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023 75
5.9.3 TOP APPLICANTS 76
FIGURE 27 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2024 76
FIGURE 28 REGIONAL ANALYSIS OF PATENTS GRANTED, 2014–2024 76
TABLE 11 TOP 12 PATENT OWNERS IN GENE EXPRESSION ANALYSIS MARKET, 2014–2024 77
TABLE 12 PATENTS IN GENE EXPRESSION ANALYSIS MARKET (2024) 77
5.10 TRADE DATA 79
5.10.1 INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS 79
TABLE 13 IMPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS) 80
TABLE 14 EXPORT VOLUME FOR INSTRUMENTS & APPARATUS FOR PHYSICAL OR CHEMICAL ANALYSIS (HS CODE-902780), 2018–2022 (TONS) 80
5.10.2 MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS 81
TABLE 15 IMPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS) 81
TABLE 16 EXPORT VOLUME FOR MICROTOMES: PARTS & ACCESSORIES OF INSTRUMENTS AND APPARATUS FOR PHYSICAL/CHEMICAL ANALYSIS (HS CODE-902790), 2018–2022 (TONS) 81
5.11 KEY CONFERENCES & EVENTS 82
5.11.1 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS IN 2024–2025 82
TABLE 17 GENE EXPRESSION ANALYSIS MARKET: CONFERENCES & EVENTS (2024–2025) 82
5.12 REGULATORY LANDSCAPE 83
5.12.1 CBER REGULATIONS ON GENE EXPRESSION ANALYSIS 83
5.12.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 18 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 84
TABLE 19 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 85
TABLE 20 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 86
TABLE 21 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 87
5.13 PORTER’S FIVE FORCES ANALYSIS 88
TABLE 22 GENE EXPRESSION ANALYSIS MARKET: PORTER’S FIVE FORCES ANALYSIS 88
5.13.1 THREAT OF NEW ENTRANTS 88
5.13.2 THREAT OF SUBSTITUTES 89
5.13.3 BARGAINING POWER OF BUYERS 89
5.13.4 BARGAINING POWER OF SUPPLIERS 89
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 89
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 90
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 90
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR GENE EXPRESSION ANALYSIS PRODUCTS & SERVICES 90
TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP FOUR END USERS 90
5.14.2 BUYING CRITERIA FOR GENE EXPRESSION ANALYSIS PRODUCTS 91
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 91
TABLE 24 KEY BUYING CRITERIA FOR TOP FOUR END USERS 91
 
6 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE 93
6.1 INTRODUCTION 94
TABLE 25 GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 94
6.2 REAGENTS & CONSUMABLES 94
TABLE 26 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 95
TABLE 27 GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 95
TABLE 28 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 29 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 96
TABLE 30 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 31 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 97
TABLE 32 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 97
TABLE 33 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 98
6.2.1 ASSAYS & KITS 98
6.2.1.1 Growing demand for streamlined and user-friendly solutions to drive market 98
TABLE 34 GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION) 99
TABLE 35 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 99
TABLE 36 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 37 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 100
TABLE 38 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 101
TABLE 39 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY REGION, 2022–2029 (USD MILLION) 101
TABLE 40 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ASSAYS & KITS, BY COUNTRY, 2022–2029 (USD MILLION) 101
6.2.2 ENZYMES 102
6.2.2.1 High uptake in molecular techniques to drive market 102
TABLE 41 GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 102
TABLE 42 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 43 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 103
TABLE 44 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 45 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 104
TABLE 46 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY REGION, 2022–2029 (USD MILLION) 104
TABLE 47 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ENZYMES, BY COUNTRY, 2022–2029 (USD MILLION) 105
6.2.3 DNA CHIPS 105
6.2.3.1 Rising demand across forensic research applications to propel market 105
TABLE 48 GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION) 106
TABLE 49 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 106
TABLE 50 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 51 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 107
TABLE 52 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 108
TABLE 53 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY REGION, 2022–2029 (USD MILLION) 108
TABLE 54 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA CHIPS, BY COUNTRY, 2022–2029 (USD MILLION) 108
6.2.4 OTHER REAGENTS & CONSUMABLES 109
TABLE 55 GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 109
TABLE 56 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 57 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 110
TABLE 58 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 59 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 111
TABLE 60 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY REGION, 2022–2029 (USD MILLION) 111
TABLE 61 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER REAGENTS & CONSUMABLES, BY COUNTRY, 2022–2029 (USD MILLION) 112
6.3 INSTRUMENTS 112
TABLE 62 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 112
TABLE 63 GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 113
TABLE 64 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 113
TABLE 65 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 66 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 114
TABLE 67 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 115
TABLE 68 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 115
TABLE 69 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 115
6.3.1 PCR 116
6.3.1.1 Growing focus on development of novel PCR kits to boost demand 116
TABLE 70 GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION) 117
TABLE 71 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 117
TABLE 72 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 73 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 118
TABLE 74 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 119
TABLE 75 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY REGION, 2022–2029 (USD MILLION) 119
TABLE 76 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PCR, BY COUNTRY, 2022–2029 (USD MILLION) 119
6.3.2 NGS 120
6.3.2.1 Increasing investments in advanced technologies to drive market 120
TABLE 77 GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION) 120
TABLE 78 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 79 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 121
TABLE 80 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 81 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 122
TABLE 82 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY REGION, 2022–2029 (USD MILLION) 122
TABLE 83 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR NGS, BY COUNTRY, 2022–2029 (USD MILLION) 123
6.3.3 DNA MICROARRAYS 123
6.3.3.1 High-throughput capabilities to propel market 123
TABLE 84 GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION, 2022–2029 (USD MILLION) 124
TABLE 85 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 124
TABLE 86 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 87 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 125
TABLE 88 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 126
TABLE 89 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY REGION 2022–2029 (USD MILLION) 126
TABLE 90 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DNA MICROARRAYS, BY COUNTRY, 2022–2029 (USD MILLION) 126
6.3.4 OTHER INSTRUMENTS 127
TABLE 91 GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 127
TABLE 92 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 93 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 128
TABLE 94 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 95 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 129
TABLE 96 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022–2029 (USD MILLION) 129
TABLE 97 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022–2029 (USD MILLION) 130
6.4 SERVICES 130
TABLE 98 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 130
TABLE 99 GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION) 131
TABLE 100 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 131
TABLE 101 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 102 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 103 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 104 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY REGION, 2022–2029 (USD MILLION) 133
TABLE 105 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 133
6.4.1 GENE EXPRESSION ANALYSIS SERVICES 134
TABLE 106 GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 134
6.4.1.1 RNA sequencing services 134
6.4.1.1.1 Rising technological advancements for drug discovery development to propel market 134
TABLE 107 GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 108 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 135
TABLE 109 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 110 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 111 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 112 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY REGION, 2022–2029 (USD MILLION) 137
TABLE 113 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR RNA SEQUENCING SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 137
6.4.1.2 Other services 138
TABLE 114 GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 115 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 116 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 117 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 118 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 119 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY REGION, 2022–2029 (USD MILLION) 140
TABLE 120 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER SERVICES, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.4.2 BIOINFORMATICS SOLUTIONS 141
6.4.2.1 Increasing demand for advanced data analytics to support market growth 141
TABLE 121 GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 122 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 123 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 124 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 125 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 126 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 127 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR BIOINFORMATICS SOLUTIONS, BY COUNTRY, 2022–2029 (USD MILLION) 144
7 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION 145
7.1 INTRODUCTION 146
TABLE 128 GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 146
7.2 DRUG DISCOVERY & DEVELOPMENT 146
7.2.1 INCREASING INVESTMENTS IN RNA-BASED THERAPEUTICS TO PROPEL MARKET 146
TABLE 129 GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 130 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 131 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 132 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 148
TABLE 133 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 134 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2022–2029 (USD MILLION) 149
TABLE 135 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2022–2029 (USD MILLION) 149
7.3 CLINICAL DIAGNOSTICS 150
7.3.1 RISING UTILIZATION OF MICROARRAYS FOR CANCER DETECTION TO DRIVE MARKET 150
TABLE 136 GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 137 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 151
TABLE 138 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 139 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 140 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 141 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2022–2029 (USD MILLION) 153
TABLE 142 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2022–2029 (USD MILLION) 153
7.4 OTHER APPLICATIONS 154
TABLE 143 GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 144 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 145 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 155
TABLE 146 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 147 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 148 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION) 157
TABLE 149 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2022–2029 (USD MILLION) 157
8 GENE EXPRESSION ANALYSIS MARKET, BY END USER 158
8.1 INTRODUCTION 159
TABLE 150 GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 159
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES 159
8.2.1 GROWING FOCUS ON DEVELOPMENT OF TARGETED THERAPIES TO BOOST DEMAND 159
TABLE 151 GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 152 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 153 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 154 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 155 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 156 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 157 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2022–2029 (USD MILLION) 162
8.3 ACADEMIC & RESEARCH INSTITUTES 163
8.3.1 INCREASING GOVERNMENT-FUNDED INVESTMENTS TO PROPEL MARKET 163
TABLE 158 GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 164
TABLE 159 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 160 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 161 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 162 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 166
TABLE 163 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 164 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2022–2029 (USD MILLION) 166
8.4 OTHER END USERS 167
TABLE 165 GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 167
TABLE 166 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 167 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 168 ASIA PACIFIC: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 169 LATIN AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 169
TABLE 170 MIDDLE EAST: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 171 GCC COUNTRIES: GENE EXPRESSION ANALYSIS MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2029 (USD MILLION) 170
9 GENE EXPRESSION ANALYSIS MARKET, BY REGION 171
9.1 INTRODUCTION 172
TABLE 172 GENE EXPRESSION ANALYSIS MARKET, BY REGION, 2022–2029 (USD MILLION) 172
9.2 NORTH AMERICA 173
FIGURE 31 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET SNAPSHOT 173
TABLE 173 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 174 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 174
TABLE 175 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 174
TABLE 176 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 177 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 178 NORTH AMERICA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 179 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 176
TABLE 180 NORTH AMERICA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 176
9.2.1 NORTH AMERICA: RECESSION IMPACT 176
9.2.2 US 177
9.2.2.1 Rising expenditure on NGS-based research to drive market 177
TABLE 181 US: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 177
TABLE 182 US: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 183 US: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 184 US: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 185 US: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 179
TABLE 186 US: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 179
TABLE 187 US: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 179
9.2.3 CANADA 180
9.2.3.1 Increasing incidence of chronic diseases to drive market 180
TABLE 188 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 180
TABLE 189 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 190 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 191 CANADA: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 192 CANADA: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 182
TABLE 193 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 182
TABLE 194 CANADA: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 182
9.3 EUROPE 183
TABLE 195 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 196 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 184
TABLE 197 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 198 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 184
TABLE 199 EUROPE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 200 EUROPE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 185
TABLE 201 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 185
TABLE 202 EUROPE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 186
9.3.1 EUROPE: RECESSION IMPACT 186
9.3.2 GERMANY 186
9.3.2.1 Rising investments in proteomics & genomics research to drive market 186
TABLE 203 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 187
TABLE 204 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 205 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 206 GERMANY: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 188
TABLE 207 GERMANY: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 208 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189
TABLE 209 GERMANY: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 189
9.3.3 UK 190
9.3.3.1 Favorable government support for genomic research projects to fuel market 190
TABLE 210 UK: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 191
TABLE 211 UK: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 212 UK: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 191
TABLE 213 UK: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 214 UK: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 215 UK: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 192
TABLE 216 UK: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 193
9.3.4 FRANCE 193
9.3.4.1 Increasing R&D in life sciences research to fuel market 193
TABLE 217 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION) 194
TABLE 218 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR REAGENTS & CONSUMABLES, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 219 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR INSTRUMENTS, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 220 FRANCE: GENE EXPRESSION ANALYSIS MARKET FOR SERVICES, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 221 FRANCE: GENE EXPRESSION ANALYSIS SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION) 195
TABLE 222 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195
TABLE 223 FRANCE: GENE EXPRESSION ANALYSIS MARKET, BY END USER, 2022–2029 (USD MILLION) 196

보고서 이미지

※본 조사보고서 [세계의 유전자 발현 분석 시장 (~2029년) : 제품별 (시약, 효소, 키트, DNA 칩, PCR, NGS, DNA 마이크로어레이), 서비스별 (RNA 시퀀싱, 바이오인포매틱스), 용도별 (신약개발, 임상진단), 최종 용도별] (코드 : BT2236-24) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 유전자 발현 분석 시장 (~2029년) : 제품별 (시약, 효소, 키트, DNA 칩, PCR, NGS, DNA 마이크로어레이), 서비스별 (RNA 시퀀싱, 바이오인포매틱스), 용도별 (신약개발, 임상진단), 최종 용도별] 에 대해서 E메일 문의는 여기를 클릭하세요.
*** 아래는 관련 보고서 소개입니다 ***

  • 세계의 생물제제 안전성 시험 시장 (~2027년) : 제품 및 서비스별 (기기, 소모품, 서비스), 용도별 (mAbs, 백신, 세포 및 유전자 치료), 시험 종류별 (무균 시험, 엔도톡신 , 마이코플라즈마, 바이오버든 ), 최종 용도별 (바이오 의약품, CDMO)
    BT3334-23 / MarketsandMarkets / 2023년 1월 / MarketsandMarkets사는 세계의 생물제제 안전성 시험 시장 규모가 2022년 36억 달러에서 2027년 68억 달러에 이르며, 예측 기간 동안 연평균 13.3%로 성장할 것으로 추정하고 있습니다. 본 조사 리포트는 세계의 생물제제 안전성 시험...“The global biologics safety testing market is projected to reach USD 6.8 billion by 2027 from USD 3.6 billion in 2022, at a CAGR of 13.3% during the forecast period. ”The growth of the global biologics safety testing market is driven by factors such as the strict regulatory scenario implemented...
  • 세계의 엑스레이 검사 시스템 시장 (~2028년) : 기술별 (필름 기반 이미징, 디지털 이미징, 컴퓨터 단층 촬영, 컴퓨터 방사선 촬영, 직접 방사선 촬영), 차원별 (2D, 3D), 산업별 (정부 인프라, 자동차), 지역별
    SE5476-23 / MarketsandMarkets / 2023년 10월 / "세계의 엑스레이 검사 시스템 시장은 2023년 8억 달러에서 2028년 11억 달러에 이르며, 예측 기간 중 CAGR은 6.2%를 기록할 것으로 전망됩니다."식품 산업에서의 안전성과 품질에 대한 주목의 증가, 회로 기판 실장의 고밀도화,...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 엑스레이 검사 시스템 시장 분석 : 기술별 7. 세계의 엑스레이 검사 시스템 시장 분석 : 차원별 8. 세계의 엑스레이 검사 시스템 시장 분석 : 산업별 9. 세계의 엑스레이 검사 시스템 시장 분석 : 지역별 10....
  • 세계의 원격 환자 모니터링 (RPM) 시장 (~2028년) : 제품별 (소프트웨어, 서비스, 기기, 순환기, 신경, 혈압 모니터, 신생아, 체중, 체온, 신경), 최종 용도별 (공급자, 병원, 진료소, 재택 의료, 환자, 보험자), 지역별
    HIT7776-23 / MarketsandMarkets / 2023년 11월 / "글로벌 원격 환자 모니터링 (RPM) 시장은 2023년 140억 달러에서 2028년 417억 달러로 2023년부터 2028년까지 연평균 20.1%의 성장률을 기록할 것으로 예상됩니다."노인 인구의 증가, 의료 접근성 확대에 대한 수요 증가, 의료 자원의...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 원격 환자 모니터링 (RPM) 시장 규모 : 유형별 7. 세계의 원격 환자 모니터링 (RPM) 시장 규모 : 용도별 8. 세계의 원격 환자 모니터링 (RPM) 시장 규모 : 최종 용도별 9. 세계의 원격 환자 모니터링 (RPM)...
  • 세계의 유전자형 분석 시장 (~2029년) : 제품 및 서비스별 (키트, 기기, 바이오인포매틱스), 기술별 (PCR, 시퀀싱, 마이크로어레이), 용도별 (약리 유전체학, 동물 유전학), 최종 용도별 (제약 및 바이오 테크놀로지 기업, 진단 연구소)
    BT3397 / MarketsandMarkets / 2024년 6월 / ...“세계의 유전자형 분석 시장은 예측 기간 동안 13.8%의 연평균 성장률로 2024년 194억 달러에서 2029년 371억 달러로 성장할 것으로 예상됩니다.”기술의 발전과 DNA 시퀀싱 비용의 하락이 이 시장의 성장을 촉진할 것으로 예상됩니다. 최근 유전성 질환의 유병률 증가로 인해 업계는 더딘 속도로 성장하고 있습니다. 또한 맞춤형 의학 및 약물 개발 분야에서 유전자형 분석은...
  • 글로벌 셀 카운팅 시장 (~2029) : 제품별, 소모품, 응용 분야별, 최종 사용자별
    BT 3379 / MarketsandMarkets / 2025년 2월 / ...2023년 108억 2천만 달러 규모로 추정되는 글로벌 셀 카운팅 시장은 2024년 111억 2천만 달러, 2029년에는 161억 4천만 달러에 달할 것으로 예상되며, 연평균 7.7%의 높은 성장률을 보일 것으로 전망됩니다. 기술의 발전, 연구 이니셔티브의 증가, 정밀 진단에 대한 수요 증가가 글로벌 셀 카운팅 시장을 주도하는 핵심 요소입니다. 형광 기반 시스템과 같은 자동화...

    • ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!